- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/06 - 1,2,3-TriazolesHydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
Patent holdings for IPC class C07D 249/06
Total number of patents in this class: 665
10-year publication summary
|
57
|
43
|
59
|
45
|
46
|
52
|
36
|
38
|
32
|
21
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4757 |
25 |
| F. Hoffmann-La Roche AG | 7796 |
11 |
| Janssen Pharmaceutica N.V. | 3150 |
11 |
| Centre National de La Recherche Scientifique | 11092 |
11 |
| The Regents of the University of California | 20868 |
9 |
| Bayer Cropscience AG | 1833 |
9 |
| Siemens Medical Solutions USA, Inc. | 1469 |
8 |
| Roche Diagnostics Operations, Inc. | 1522 |
7 |
| Imago Biosciences, Inc. | 39 |
7 |
| The University of Queensland | 651 |
7 |
| Sigilon Therapeutics, Inc. | 112 |
7 |
| E. I. du Pont de Nemours and Company | 3464 |
6 |
| Northwestern University | 3567 |
6 |
| Arcus Biosciences, Inc. | 166 |
6 |
| FMC Corporation | 813 |
6 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 177 |
6 |
| The Research Foundation for The State University of New York | 1764 |
6 |
| Yale University | 2565 |
6 |
| Pfizer Inc. | 3414 |
5 |
| Takeda Pharmaceutical Company Limited | 2698 |
5 |
| Other owners | 501 |